AlphAIAlphAI — Financial news for AI agents
stocktitan.netOCT 11 min read$CCEP

Coca-Cola Europacific applies to list 25,057 shares

Coca-Cola Europacific Partners (CCEP) filed a Form 6-K with the SEC, disclosing share acquisitions by executives. CFO Edward Walker, General Counsel Svetlana Walker, and Chief Commercial Officer Stephen Lusk each acquired shares under the UK Share Plan and UK Shareshop. The transactions occurred on September 21, 2026, on the Nasdaq Stock Market.

Original reporting
stocktitan.net
Published Oct 1, 2026, 3:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 6:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$CCEP
Neutral
high confidence
Mentioned
$CCEP
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CCEPNeutralLow
01

Why it matters

The disclosed purchases are minor and unlikely to move the stock materially.

02

Market read

Limited relevance; filing is a routine disclosure of small insider trades.

03

What to watch

Potential future larger purchases not disclosed; current filing is routine.

Relevance 4/10Novelty 2/10Timing: immediate filing date

Background

Coca-Cola Europacific Partners plc filed a Form 6‑K reporting insider transactions for three senior executives.

Company-level read

Ticker impact

$CCEPNeutralHigh confidence
Context

Form 6-K discloses insider purchases of ordinary shares by CFO, General Counsel, and CCO of Coca-Cola Europacific Partners plc.

Expected impact

likely neutral to slight positive as market prices in modest insider buying.

Evidence & confidence

Transactions involve only a few shares at modest prices; market impact is limited.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

Insider buying may signal confidence, but size is too small to affect price.

Key entities

  • Executive
    Edward Walker

    Chief Financial Officer

  • Executive
    Svetlana Walker

    General Counsel and Company Secretary

  • Executive
    Stephen Lusk

    Chief Commercial Officer

Read at source← All news

Related articles

OCT 5
$CCEPMed

UBS reiterates Neutral rating on Coca-Cola Europacific Partners stock

UBS reiterated a Neutral rating on Coca-Cola Europacific Partners (CCEP) with a $107.00 price target, citing 5.4% Q3 organic sales growth forecast. The stock trades at $100.50, above InvestingPro’s Fair Value estimate. UBS expects growth in Europe and Asia Pacific, with potential for raised full-year revenue guidance. CCEP reported H1 2026 revenue of EUR 10.7 billion, up 6.1%, and EPS growth of 10.6%. Analysts have mixed views on its valuation and outlook.

investing.com2 min
SEP 24
Low

Coca Cola Europacific Partners (ENXTAM:CCEP) Board Exit Leaves Its Undervalued Case In Focus

Coca-Cola Europacific Partners (CCEP) is under scrutiny after independent non-executive director Nathalie Gaveau resigned, prompting a review of board roles. The company's share price is €88.3, down 6.26% over the past month but up 17.42% year-to-date and 116.77% over five years. Analysts suggest CCEP is 8% undervalued with a fair value of €95.68, citing strong long-term growth prospects in emerging markets and digital investments.

simplywall.st2 min
SEP 14
$CCEPHigh

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 403,748 ordinary shares from 7 to 11 September 2026, totaling approximately $43.5 million (USD) and £31.2 million (GBP) on US and London trading venues, respectively. The shares were bought as part of the company's EUR 1 billion share buyback program announced in February 2026. The repurchased shares will be cancelled.

investegate.co.uk2 min
SEP 4
$CCEPHigh

CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) fell 3.1% after J.P. Morgan re-initiated coverage with an Underweight rating and a $92 price target, citing valuation concerns and potential slowdown in volume growth. The stock has faced scrutiny due to its premium valuation, despite solid first-half 2026 results. Institutional investors have recently adjusted their positions in CCEP.

quiverquant.com2 min
AUG 8
$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

aol.com4 min